▲ | umvi 4 days ago | |||||||||||||||||||||||||||||||
This is great news. Any type of pancreatic function restoration is also potentially good for Type 1.5 (which constitute a sizable chunk of misdiagnosed T2Ds) where the body attacks more slowly (over the course of years) instead of acutely like traditional T1D and so doctors assume it's insulin resistance instead of pancreatic function decline since they both present with the same symptom - hyperglycemia. | ||||||||||||||||||||||||||||||||
▲ | tracker1 4 days ago | parent | next [-] | |||||||||||||||||||||||||||||||
It would be nice if fasting insulin and other markers were tested more regularly beyond fasted glucose and a1c, since those can vary for other reasons. Not to mention catching those developing insulin resistance potentially years ahead. | ||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||
▲ | Lu2025 4 days ago | parent | prev [-] | |||||||||||||||||||||||||||||||
BTW Covid harms pancreatic cells that produce insulin via autoimmune mechanisms. |